5-10
2026
影响因子区间
161天
平台估算
52%
2025
中国作者发文占比
—
收费
期刊简介:Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
【译文】癌症基因治疗是癌症研究人员和临床医生必不可少的基因和细胞治疗资源,为读者提供关于癌症基因和细胞治疗最新发展的最新信息。该期刊发表原创的实验室和临床研究论文、病例报告和综述文章。发表的主题包括RNA干扰方法、耐药性、造血祖细胞基因转移、癌症干细胞、细胞治疗、同源重组、核酶技术、反义技术、肿瘤免疫治疗和肿瘤抑制因子、转化研究、癌症治疗、基因递送系统(病毒和非病毒)、反基因治疗(反义、siRNA和核酶)、细胞凋亡;机制和疗法、疫苗开发、免疫学和免疫治疗、DNA合成和修复。癌症基因治疗发表基因转移/基因治疗和细胞治疗领域实验室研究、临床前研究和临床试验的结果。发表的论文类型包括原创研究论文;病例报告;简报;关于药物耐药性/敏感性、基因治疗、细胞治疗、肿瘤抑制因子和抗癌基因治疗、细胞因子/肿瘤免疫治疗等主要领域的综述文章;行业观点;以及编辑信。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |